Economic Outlook - Increasing discussions about a potential recession in 2026 as the economy shows signs of slowing after a prolonged expansion [1] - Current U.S. economy described as stable but uneven, with household spending focusing more on essentials rather than discretionary items [2] - Businesses facing margin pressure due to higher costs and selective consumer behavior, raising the risk of slower growth heading into 2026 [2] Consumer-Staple Sector - In uncertain or low-growth periods, investors tend to shift from cyclical sectors to consumer-staple stocks, which have steady demand and predictable cash flows [3] - Consumer-staple companies sell essential products that consumers continue to purchase regardless of economic conditions, benefiting from strong brands and effective cost management [4] Investment Opportunities - Three consumer-staple stocks identified as strong investment opportunities: Estee Lauder (EL), Turning Point Brands (TPB), and Monster Beverage (MNST) [5] - All three companies have gained over 35% in the past year and hold a Zacks Rank 1 (Strong Buy), indicating favorable earnings trends and strong fundamentals [5] Estee Lauder (EL) - Estee Lauder shows early recovery signs with a focus on innovation and efficiency, supported by its Beauty Reimagined strategy [9][10] - The Zacks Consensus Estimate for EL's EPS suggests growth of 41.7% and nearly 36% for the current and next fiscal years, respectively [11] Turning Point Brands (TPB) - TPB has experienced significant growth of 87.3% over the past year, combining stable cash flows from legacy brands with growth from modern oral nicotine products [12] - The Zacks Consensus Estimate for TPB's EPS indicates growth of 50.6% and 7.1% for the current and next fiscal years, respectively [14] Monster Beverage (MNST) - MNST has gained 46.2% in the past year, benefiting from a growing global energy drink market and strong brand loyalty [15] - The Zacks Consensus Estimate for MNST's EPS suggests growth of 22.2% and 13.2% for the current and next fiscal years, respectively [17] Conclusion - If economic growth slows in 2026, consumer-staple stocks like EL, TPB, and MNST may provide relative stability due to their essential products and strong brand positioning [18]

Nicotine-pouch use is growing in Britain especially among young men, a study in the Lancet medical journal found, a trend that could be cut short by a government ban on sales to people under the age of 18 https://t.co/cqdPcEH1Un ...

Group 1 - Philip Morris International Inc. (PM) is recognized as one of the 15 Best Blue-Chip Stocks with Growing Dividends [1] - Ferrari N.V. has renewed and expanded its partnership with Philip Morris, which will take effect on January 1, 2026 [2][3] - The new agreement designates Philip Morris as a Premium Partner of Scuderia Ferrari HP and Series Partner of the Ferrari Challenge Trofeo Pirelli [3] Group 2 - The partnership between Ferrari and Philip Morris has lasted over 50 years, emphasizing a long-standing collaboration [4] - Stefano Volpetti, President of Smoke-Free Products at PMI, highlighted the commitment to innovation and the replacement of cigarettes through this partnership [4] - Philip Morris operates in over 180 countries, with Marlboro being its most recognized brand [5]

Core Viewpoint - Coca-Cola is positioned to be a more compelling long-term investment compared to Altria, the leading tobacco company, due to its diversified product portfolio and growth potential in a changing market landscape [5]. Group 1: Altria Overview - Altria is a leading tobacco company in America, known for its flagship Marlboro brand, which holds nearly half of the retail cigarette market [2]. - The company is expanding its portfolio with smoke-free products like e-cigarettes and nicotine pouches as adult smoking rates decline [2]. - Altria has consistently increased its dividend since spinning off its international business in 2008, currently offering a forward yield of 7.2% and trading at ten times forward earnings [3]. Group 2: Coca-Cola Overview - Coca-Cola has developed a diverse range of products beyond its traditional sugary sodas, including bottled water, fruit juices, teas, and alcoholic beverages, which has helped mitigate the decline in soda consumption [8]. - The company reported organic sales growth of 16% in 2022, 12% in 2023, and is projected to maintain 12% growth in 2024, contrasting with Altria's declining sales [9]. - Coca-Cola operates a capital-light business model, producing only concentrates and syrups, which allows for high gross margins and more cash for marketing and dividends [10]. Group 3: Financial Performance and Outlook - Analysts expect Coca-Cola's adjusted EPS to grow at a CAGR of 6% from 2024 to 2027, while Altria's adjusted EPS is expected to grow at a CAGR of 4% [12]. - Coca-Cola has a forward dividend yield of 2.9% and has raised its payout for 63 consecutive years, making it a "Dividend King" [13]. - Over the past decade, Coca-Cola has delivered a total return of 126%, while Altria's total return was 99%, indicating Coca-Cola's stronger long-term performance [14]. Group 4: Market Trends and Future Prospects - The S&P 500 is near its all-time high, and the Federal Reserve is expected to cut benchmark rates in 2026, which may lead investors to favor dividend stocks like Coca-Cola over growth stocks [16]. - Coca-Cola is anticipated to benefit from this trend, positioning it as a better investment option compared to Altria for 2026 and beyond [16].

Core Insights - Altria Group, Inc. is observing significant growth in the e-vapor category, with U.S. adult usage projected to reach approximately 21 million consumers by the end of Q3 2025, primarily driven by disposable products [1][9] E-Vapor Market Dynamics - The recent growth in the e-vapor market is largely attributed to disposable e-vapor products, which have added around 2.4 million users and now represent over 60% of the category. These products are typically flavored, low-priced, and widely available, although many lack FDA authorization [2][9] - Altria's e-vapor business, centered around the NJOY brand, focuses on FDA-authorized products, which limits its participation in the segment that is driving most of the new user adoption [2] Regulatory Environment - Altria has advocated for stronger enforcement against unauthorized e-vapor products. Federal agencies have recently intensified actions against illicit e-vapor, including coordinated raids and large-scale seizures, indicating increased regulatory scrutiny in the category [3][9] Financial Performance and Valuation - Altria recorded a non-cash goodwill impairment charge of $873 million in its e-vapor business during the first nine months of 2025, reflecting the challenges faced in this segment [4] - The company's shares have increased by 1% over the past month, compared to the industry's growth of 1.6% [8] - Altria's forward price-to-earnings ratio stands at 10.57X, which is lower than the industry average of 14.19X [10] Earnings Estimates - The Zacks Consensus Estimate for Altria's 2025 earnings per share has increased by 1 cent to $5.44, while the estimate for 2026 has decreased by 1 cent to $5.56 [11]

Core Insights - Altria has a current dividend yield of 7%, significantly higher than the S&P 500 average, although it is below its five-year average of 7.7% [1][6] - The company has increased its annual dividend for 56 consecutive years, qualifying it as a Dividend King, with a target payout ratio of around 80% of adjusted earnings per share [6] Financial Metrics - Altria's annual dividend is $4.24 per share, requiring ownership of 472 shares to generate $500 in annual dividend income, equating to a total investment of approximately $27,716 at the current stock price of $58.72 [2][5] - The current market capitalization of Altria is $99 billion, with a stock price of $59.32 [5] Business Performance - Altria's business is facing challenges due to a decline in the number of U.S. adult smokers, leading to reduced volume; however, the company has managed to offset some of this decline through its pricing power [4] - Despite stagnant revenue growth, Altria has maintained a gross margin of 71.98% [6]

Leadership Transition - Altria Group's CEO Billy Gifford will step down after the annual shareholder meeting on May 14, 2026, with Salvatore "Sal" Mancuso appointed as his successor [1][4] - Mancuso has been with Philip Morris since 1990, holding various finance roles, including senior vice president of finance and procurement [3] - Gifford will remain with Altria as a consultant until the end of 2026 to ensure a smooth transition [5] New CFO Appointment - Heather Newman will succeed Mancuso as Chief Financial Officer after the transition [2] - Newman has been in her current role since 2019, overseeing corporate development, international strategy, and Altria's digital and technology organization [6] Executive Insights - Board Chair Kathryn McQuade expressed confidence in Mancuso's industry knowledge and commitment to Altria's 2028 Enterprise Goals [4] - Gifford highlighted his confidence in Mancuso's leadership abilities and commitment to Altria's strategy [5]

Group 1 - President Donald Trump's potential reclassification of marijuana has led to significant gains for companies like Cronos Group Inc. (CRON) [1] - The focus is on identifying high-quality companies with a proven ability to reinvest capital for impressive returns, aiming for a long-term capital compounding capability [1] - A conservative investment strategy is primarily adopted, with occasional pursuit of favorable risk-reward opportunities to maintain overall portfolio stability [1]

Core Viewpoint - Altria Group has shown a total return of 13.5% over the past year, primarily driven by high dividend payments, but it still underperformed compared to the S&P 500's total return of 15.6% [2][3]. Performance Analysis - Altria's stock price increased by 6.9% over the past year, which is significantly lower than the S&P 500's increase of 13.8% [2]. - A $1,000 investment in Altria would have grown to $1,135, while the same investment in the S&P 500 would have reached $1,156 [3]. Dividend Insights - Altria has a strong focus on dividends, with the board recently increasing the payout by 3.9% to $1.06 per share, resulting in a dividend yield of 7.2%, which is substantially higher than the S&P 500's yield of 1.1% [4][6]. Business Challenges - Altria's revenue from smokeable products, particularly cigarettes, has been declining, with a 1.3% drop in the third quarter to $4.6 billion. The company is facing challenges with falling cigarette volume and a decrease in market share, especially for its Marlboro brand [5]. Investment Considerations - Despite the attractive dividend yield, the long-term business prospects for Altria appear bleak, leading to a recommendation to avoid investing in the shares [5].

Sales of vapes, cigarettes and other tobacco products slumped more than any other grocery category in the UK, a survey showed, a sign that tighter regulations and health concerns are curbing smoking habits https://t.co/xgfED1x6c8 ...